Citations

Clear

1320 citation(s) found for "Nguyen, Vi".

Abstract 166: Rewiring the dendritic cell: Regulatory T cell axis sensitizes prostate cancer to immunotherapy.
Hill, Jessica C., Copple, Kade, Nguyen, Phuong, Bhattacharya, Nilika, Lancaster, Jessica N., Ager, Casey R. , Jugler, Collin , Lancaster, Jessica N.

Mayo Clinic

Cancer Research | April 3, 2026 | Volume: 86 | Issue: 7_Supplement | Pages: 166-166

10.1158/1538-7445.am2026-166 Get It

Abstract Introduction: The prostate cancer (PCa) tumor microenvironment (TME) is immunosuppressive and resistant to immune checkpoint blockade (ICB). Based on multi-omic single cell correlatives of response to neoadjuvant Fc-enhanced (FcE) αCTLA-4 in high-risk localized PCa (NCT04301414), we explored how modulating the balance between regulatory T cells (Tregs) and dendritic cells (DCs) in the PCa TME affects sensitivity to ICB. Methods: We leveraged three single cell transcriptomic atlases of PCa to assess how Tregs and DC frequencies are dynamically regulated during PCa progression. To investigate responses to Treg depletion (via FcE-αCTLA-4) alongside DC expansion (via Flt3L-Ig) and stimulation (via STING agonist ADU-S100) in PCa, we employed the castration-sensitive MycCaP PCa model and 45-parameter spectral flow cytometry. To investigate novel direct mechanisms of DC stimulation by FcE-αCTLA-4 via Fcγ receptor (FcγR) engagement, we optimized reductionist in vitro assays involving bone marrow-derived DCs (BMDCs) from wild-type (WT) mice or mice deficient in activating FcγRs (Fcer1g-/-) or inhibitory FcγRIIb (Fcgr2b-/-). To validate this effect in vivo we established a tumor antigen-specific T cell priming assay with both flow cytometry and ex vivo 2-photon live cell imaging readouts. Results: In three independent single cell transcriptomic PCa atlases, we find cDC2 frequencies are significantly decreased in advanced PCa while effector Tregs (TNFRSF9+) increase in proportion. Hypothesizing that excessive Treg function and DC insufficiency drive ICB resistance in PCa, we find in vivo DC expansion (Flt3L-Ig) prior to hormonal therapy, Treg depletion (FcE-αCTLA-4), and in situ DC stimulation (ADU-S100) drives robust control of established MycCaP tumors, with 87% of animals tumor-free 40-days post-treatment (27/31). Using 45-parameter spectral flow cytometry we find FcE-αCTLA-4 drives DC activation prior to Treg depletion in the TME, supporting a novel direct mechanism of DC modulation by FcE-αCTLA-4. In vitro, we find cell-associated FcE-αCTLA-4 is sufficient to drive BMDC maturation in an FcγR-dependent manner. In vivo, FcE-αCTLA-4 augments DC-mediated T cell priming in an FcγR-dependent manner. Ongoing experiments are investigating how FcE-αCTLA-4 shapes DC-T cell interactions via FcγR engagement and how DC/Treg axis modulation can be optimized to improve long-term curative response rates in the MycCaP model. Conclusions: DC insufficiency and effector Treg differentiation are hallmarks of advanced PCa. Enhancing DC number and function concomitant with Treg depletion can drive effective antitumor immunity in a pre-clinical PCa model. Direct DC modulation via FcγR engagement represents a novel mechanism of response to CTLA-4-targeted ICB. These findings will inform ongoing translation of FcE-αCTLA-4 agents and development of novel immunotherapy strategies for PCa. Citation Format: Jessica C. Hill, Kade R. Copple, Collin Jugler, Phuong Nguyen, Nilika Bhattacharya, Jessica N. Lancaster, Casey R. Ager. Rewiring the dendritic cell: Regulatory T cell axis sensitizes prostate cancer to immunotherapy [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 166.
Whole Metagenomic Profiling Identifies a Gut Microbial Signature for Chronic Pancreatitis via Machine Learning
Bartelli, Thais F., Sahin, Ismet, Hoffman, Kristi L. , Petrosino, Joseph, Zhao, Jing, Wood, Amy, Ayvaz, Tulin, Surathu, Anil , Cagigas, M. Navarro , Barcenas, Erick Carrasco, Mata, Tomera, Nguyen, Vincent Kim, Zulbaran-Rojas, Alejandro, White, James R., Ajami, Nadim, Yadav, Dhiraj, Conwell, Darwin L., Serrano, Jose, Pandol, Stephen J., Fogel, EL, Eden, Stephen K Van Den, Vege, S. S., Topazian, Mark D., Park, Walter G., Hart, Phil A., Forsmark, Chris, Bellin, Melena D., Maitra, Anirban, Kim, Michael, Buren, George Van , Fisher, William E., McAllister, Florencia , Behalf, on, Park, Walter G. , Bartelli, Thais Fernanda , Baydogan, Seyda , Petrosino, Joseph F. , Blackburn, Kyle Warren , Zulbaran‐Rojas, Alejandro , Li, Li , Faraoni, Erika Yanil , White, James R., Ajami, Nadim J. , Yadav, Dhiraj, Conwell, Darwin L. , Serrano, José , Pandol, Stephen J , Vege, Santhi Swaroop , Topazian, Mark , Forsmark, Chris E. , Bellin, Melena D. , Maitra, Anirban , Bhutani, Manoop S.

Mayo Clinic

Pancreas | March 30, 2026 | Volume: 55 | Issue: 5 | Pages: e458-e468

10.1097/mpa.0000000000002618 | PMID 41910593 Get It

Background: Pancreatitis significantly alters the microbial composition of the oral and intestinal compartments, causing dysbiosis that may contribute to disease mechanisms and potentially serve as a basis for diagnosis or treatment. Objective: To determine whether the oral or gut microbial signature can classify chronic pancreatitis (CP). Methods: Stool samples (n=707) were collected from participants in the Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies (PROCEED). Samples were distributed among 200 healthy (HC), 310 CP, 49 acute pancreatitis (AP), and 148 recurrent acute pancreatitis (RAP). In addition, saliva samples were collected for a subset of participants (n=156). Whole genome sequencing was performed to assess microbiome composition. Machine learning algorithms were utilized to identify a signature with microbial features predictive of CP. Results: Gut alpha diversity was significantly decreased in AP, RAP, and CP compared with HC, with CP exhibiting the lowest diversity. In contrast, oral microbial diversity showed no significant variation across groups. Beta diversity analysis revealed distinct gut microbiome compositions between HC and pancreatitis subtypes, with CP showing the most pronounced differences. Random forest models using gut microbial species demonstrated robust predictive performance for CP using a minimum of 10 species (Area under the curve—AUC: 0.834; accuracy: 0.774). Despite similarities in gut microbiome composition across pancreatitis subtypes, a unique gut microbial signature for CP was identified highlighting the microbiome’s potential in CP diagnosis. Conclusion: Our study reveals a gut microbial signature predictive of CP using machine learning models in a large US multi-institutional cohort.
Outcomes and Surgical Management of Malignant Rhabdoid Tumor of the Kidney: A Report From the Pediatric Surgical Oncology Research Collaborative
Paredes, Anghela Z. , Beckhorn, Catherine B , Fusco, Joseph , McKay, Katlyn G. , Kontchou, Nelly‐Ange T. , Kastenberg, Zachary J. , Roach, Jonathan P. , Myers, Emily K. , Cost, Nicholas G. , Mullapudi, Bhargava , Jensen, Amanda , Dasgupta, Roshni, Lundstedt, John, Brungardt, Joseph G. , Davidoff, Andrew M., Murphy, Andrew J., Piché, Nelson , Le‐Nguyen, Annie, Craig, Brian T. , Schuh, Jennifer M , Cromeens, Barrett P., Lopez, A. Javier, Mello, Kelsey , Short, Joshua , Petroze, Robin T. , Rajavel, Shay, Thompson, Grace R., Fialkowski, Elizabeth , Fowler, Kathryn , Martchenke, Nathan, Rich, Barrie S. , Glick, Richard D. , Doyle, Kathleen , Abril, Paige, Seemann, Natashia M. , Davidson, Jacob B., Wilson, Claire A. , Joshi, Devashish , Stellon, Michael , Hammoud, Maya M. , Williams, Keyonna M , Grant, Christa N. , Gorgy, Merit, Debertin, Julia , Cameron, Danielle B. , Stetson, Alyssa , Lee, William G., Barkhordar, Aaron, Austin, Mary, Coakley, Brian A. , Murphy, Joseph T., Pitonak, M., Boehmer, Chloé , Beckhorn, Catherine , Kastenberg, Zachary J , Lautz, Timothy , Brungardt, Joseph G , Murphy, Andrew J , Thompson, Grace R , Glick, Richard D , Seemann, Natashia M , Joshi, Devashish , Stellon, Michael , Dimmer, Alexandra M , Williams, Keyonna , Polites, Stephanie F. , Stetson, Alyssa , Lee, William G , Barkhordar, Aaron , Malek, Marcus M , Rinehardt, Hannah , Tracy, Elisabeth T. , Leraas, Harold J. , Hoyt, David , Marchese, Charles R. , Lautz, Timothy B. , Carter, Michela M. , Dasgupta, Roshni , Talbot, Lindsay J , Davidoff, Andrew M. , Aldrink, Jennifer H. , Mansfield, Sara A. , Lal, Dave R. , Mannava, Sindhu V , Castle, Shannon L. , Lopez, Adriana, Rajavel, Shay , Mattei, Peter , Rothstein, David H. , Fowler, Kathryn, Brown, Erin G. , Le, Hau D. , Ahmed, Tamer, Ehrlich, Peter F. , Gorgy, Merit , Kim, Eugene S. , Kahan, Anastasia M , Murphy, Joseph T., Malek, Marcus M.

Mayo Clinic

Pediatric Blood & Cancer | March 27, 2026 | Volume: 73 | Issue: 6 | Pages: No page available

10.1002/1545-5017.70296 | PMID 41889149 Get It

ABSTRACT Purpose Malignant rhabdoid tumor of the kidney (MRTK) is a rare, aggressive tumor seen in young children. The optimal timing of resection for locally advanced tumors is not well‐defined. The purpose of this study is to evaluate modern oncologic outcomes and the impact of surgical timing. Methods A multicenter retrospective review was performed by institutions participating in the Pediatric Surgical Oncology Research Collaborative. Children younger than 21 years old with MRTK diagnosed between 2000 and 2022 were included. Results Sixty‐nine patients were identified with MRTK and met the inclusion criteria. Median age of diagnosis was 10.1 months. Overall survival (OS) at 1, 5, and 10 years was 49%, 32%, and 19%, respectively. Patients with local Stage III disease who underwent upfront resection ( n = 18) compared to those who had delayed resection after NAT ( n = 15) had a similar OS, median OS greater than 60 months versus 14.6 months, respectively; p = 0.396. The surgical timing groups were balanced in terms of the presence of metastasis, length of follow‐up, and tumor characteristics. There was one occurrence of primary intraoperative tumor spill and two occurrences of organ injury in the upfront resection group compared to none in the delayed resection group. Conclusion MRTK carries a poor prognosis despite multimodal treatment. Histologic diagnosis may not be confirmed at presentation, and MRTK cannot be reliably distinguished from Wilms tumor on imaging alone. As overall survival is similar, the decision regarding surgical timing in locally advanced tumors should be individualized based on perceived resectability, balancing the risk of intraoperative complications against the possibility of tumor progression during neoadjuvant therapy.
Impact of Operative Order on Postoperative Outcomes in Patients Undergoing Lumbar Fusion and Total Hip Arthroplasty
Al-Saidi, Nadir, Al-Saidi, Neil, Nguyen, Ryan T. , Reilly, Alison, Mohammed, Dina, Bydon, Mohamad, Dominari, Asimina , Al-Saidi, Nadir , Ryan, Nguyen, Mohammed, Dina, Bydon, Mohamad

Mayo Clinic

Spine | March 27, 2026 | Volume: 51 | Issue: 11 | Pages: 813-822

10.1097/brs.0000000000005700 | PMID 41887675 Get It

Study Design. Systematic review and meta-analysis. Objective. To assess how operative order affects clinical outcomes and complications in patients with concomitant lumbar spinal and hip pathologies. Summary of Background Data. Concomitant lumbar spinal and hip pathologies are becoming increasingly prevalent in the growing population. Determining the optimal operative order for surgical treatment remains challenging, particularly when comparing spine arthrodesis followed by hip arthroplasty (SAHA) with hip arthroplasty followed by spine arthrodesis (HASA). Prior studies report conflicting results regarding outcomes and complications. Methods. A comprehensive literature search was performed to identify studies reporting on postoperative outcomes and complications in patients with concomitant lumbar spinal and hip pathologies. Random-effects model meta-analysis of pooled outcomes was performed comparing operative order groups (SAHA and HASA), with postoperative complications and revisions being our primary endpoints. Results. A total of 22 studies, yielding 161,326 patients who received surgical treatment for concomitant lumbar spinal and hip pathologies, were included. The majority of patients underwent SAHA (pooled estimate: 88.4%, 95% CI: 76.9–96.3%, P =0.01). Females comprised 56.1% (95% CI: 49.2–62.8%) of the study population. The mean age was 70.6±6.4 years, and the mean follow-up duration was 2.6±2.1 years. The mean number of treated levels was 2.1±1.4. No significant differences were noted between the SAHA and HASA groups with respect to complications, including hip dislocation ( P =0.7), mechanical loosening ( P =0.8), periprosthetic fractures ( P =0.7), deep venous thrombosis (DVT) ( P =0.8), and infection ( P =0.9). Revisions were required in 3.6% of patients in the SAHA group (95% CI: 2.5–4.9%) and 2.6% of patients in the HASA group (95% CI: 0.5–6.2%, P =0.5). Conclusion. Among patients surgically treated for concomitant lumbar spinal and hip pathologies, SAHA was significantly more commonly performed than HASA. Our analysis shows that postoperative complications and revisions did not significantly differ depending on operative order.
Coronary Artery Bypass Grafting: History, Landmark Trials, and the Evolution of Surgical Practice
Nguyen, Darren, Khalid, Arbab , Tak, Nadia, Cyrus, Tillmann, Hartnett, Sigurd, Tak, Tahir

Mayo Clinic

International Journal of Angiology | March 24, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/a-2781-5103 Get It

Abstract Coronary artery bypass graft (CABG) surgery is one of the most commonly performed surgeries in the United States. It remains the gold standard of coronary artery revascularization despite the introduction of percutaneous coronary interventions and advancements in medical therapy. First conceptualized in the 1900s, CABG underwent decades of trials, experimentation, innovations, and even failures. Despite the challenges, CABG continued to innovate, overcoming the complexities of coronary artery disease and improving patient outcomes. This manuscript aims to discuss the beginnings, evolution, and future of CABG.
Expanding the molecular grading criteria in IDH-mutant astrocytoma
Virata, Michael , Samanamud, Jorge , Slocum, Connie, Kandoi, Shrishtee , Nguyen, Phuong , Savani, Milan R. , Shi, Diana D, Sharma, Sachein , Hiya, Satomi , Maldonado-Díaz, Carolina , Clare, Kevin, Vij, Meenakshi, Mir, Ema, Nishikawa, Y , Umphlett, Melissa , Yong, Raymund L. , Bederson, Joshua B. , Silva-Hurtado, Thenzing J. , Brem, Steven, Hambardzumyan, Dolores, Snuderl, Matija, Viapiano, Mariano S. , McBrayer, Samuel K. , Hatanpaa, Kimmo J. , Tsankova, Nadejda M. , Richardson, Timothy E. , Virata, Michael Christian , Samanamud, Jorge , Nguyen, Phuong , Yokoda, Raquel T , Vij, Meenakshi , Mir, Ema , Yong, Raymund L , Silva-Hurtado, Thenzing J , Brem, Steven , Hambardzumyan, Dolores , Snuderl, Matija , Viapiano, Mariano S , Abdullah, Kalil G , McBrayer, Samuel K , Tsankova, Nadejda M , Richardson, Timothy E , Shi, Diana D. , Yokoda, Raquel T. , Snuderl, Matija , Walker, Jamie M.

Mayo Clinic

Neuro-Oncology | March 24, 2026 | Volume: 28 | Issue: 8 | Pages: 1921-1932

10.1093/neuonc/noag069 | PMID 41903203 Get It

Abstract Background IDH-mutant astrocytomas are classified as WHO grade 4 in the presence of conventional high-grade histologic features and/or homozygous CDKN2A/B deletion in the 5th edition of the WHO Classification of Central Nervous System Tumour guidelines. However, work over the past decade has indicated a number of other molecular alterations that warrant consideration as potential prognostic markers. Methods We used univariate Kaplan-Meier and multivariate Cox proportional hazards regression analysis to evaluate the prognostic effects of homozygous CDKN2A/B deletion, CDK4 amplification, CCND2 amplification, PDGFRA amplification/mutation, PIK3R1 mutation, PIK3CA mutation, MYCN amplification, EGFR amplification/mutation, TERT promoter mutation, and grade 4 histologic features in two independent cohorts of WHO grade 2-4 IDH-mutant astrocytoma (n = 840 and n = 367). Results The presence of CDK4 amplification, CCND2 amplification, PDGFRA alteration, PIK3R1 mutation, MYCN amplification, and EGFR alteration were each associated with reduced overall survival compared to WHO grade 2/3 astrocytomas without these molecular features. 17.7% (148/837) of otherwise grade 2/3 astrocytomas had one or more of these molecular criteria, with resulting intermediate clinical outcome in terms of overall survival (median survival of 67.3-82.0 months) compared to grade 2/3 astrocytomas without these molecular features (median survival of 135.0-140.7 months) and grade 4 astrocytomas (median survival of 35.3-45.0 months). Conclusions The presence of CDK4, CCND2, PDGFRA, PIK3R1, MYCN, and EGFR alterations result in an intermediate patient survival in IDH-mutant astrocytoma. Adding these molecular alterations should be considered in future diagnostic classification systems to improve stratification of high-risk patients.
Kv1.3 as an upstream regulator of oxidative stress-mediated neuroinflammation following organic dust exposure in murine in vitro, ex vivo, and in vivo models
Shrestha, Denusha, Malovic, Emir , Karriker, Locke A. , Robertson, Alan P. , Nguyen, Hai M. , Wulff, Heike, Charavaryamath, Chandrashekhar, Bhat, Sanjana Mahadev , Massey, Nyzil , Choudhary, Shivani, Wulff, Heike , Kanthasamy, Anumantha G. , Charavaryamath, Chandrashekhar

Mayo Clinic

Frontiers in Toxicology | March 23, 2026 | Volume: 8 | Issue: No issue available | Pages: No page available

10.3389/ftox.2026.1765108 | PMID 41948413 Get It

Introduction Inhalation of organic dust from concentrated animal production operations induces inflammation in the brain and respiratory tract. We investigated the role of the potassium channel Kv1.3 in models of organic dust (OD)-induced neuroinflammation. Kv1.3 channels play multifaceted roles in microglial immune modulation, cancer, and neurodegenerative diseases, and represent a potential therapeutic target. Methods We used in vivo (C57BL/6 mice), in vitro (microglial cell line, and primary microglia), and ex vivo (brain slice culture) models of OD-induced neuroinflammation. Sterile OD extract (ODE) was prepared, and mice were exposed to either normal saline or ODE intranasally for 5 weeks (5 days/week) to simulate an occupational exposure scenario. Primary microglia were isolated from neonatal mice for total RNA sequencing (RNA-seq). Results The ODE-induced expression of Kv1.3 was quantified using in vitro and ex vivo models with and without PAP-1 treatment. Exposure-induced changes in cytokines and markers of reactive species were measured. Using western blot, we quantified phosphorylated p38 MAPK (p-p38 MAPK) and NOX2. We measured microglial Kv1.3 currents using whole-cell patch-clamp. Exposure to ODE increased the expression of Kv1.3 and p-p38 MAPK in mouse microglia without affecting the Kv1.3 currents at the cell surface. Exposure increased the levels of inflammatory cytokines and NOX2. Kv1.3 inhibition with PAP-1 decreased inflammatory markers (TNF-α in BV2 microglia and IL-6 in Brain slice cultures and BV2 microglia), levels of Kv1.3, p-p38 MAPK, NOX2, and nitrites. Conclusion Our study revealed that pharmacological inhibition of Kv1.3 potassium channels reduces ODE-induced neuroinflammation by decreasing inflammatory and oxidative stress markers.
A 3D‐Printed Compact Multi‐Nozzle Microfluidic Device for Scalable Microencapsulation of Pluripotent Stem Cells
Nguyen, Quoc Huynh, Tuan, Quang, Jaberi, Seyed Hassan , Baskaran, Harihara , Stybayeva, Gulnaz, Peterson, Quinn, Revzin, Alexander , Nguyen, Huynh Quoc , Nguyen, Quoc Huynh , Nguyen, Kianna, Che, Quang Tuan, Choi, Daheui , Revzin, Alexander , Nguyen, Kianna M. , Gwon, Kihak , Peterson, Quinn

Mayo Clinic

Advanced Healthcare Materials | March 21, 2026 | Volume: 15 | Issue: 20 | Pages: No page available

10.1002/adhm.202600018 | PMID 41863475 Get It

ABSTRACT Encapsulation of human pluripotent stem cells (hPSC) has high relevance for biomedical applications ranging from tissue engineering to drug screening and cellular therapies. Microcapsules serve a multitude of purposes—from promoting hPSC organization into spheroids to enabling scalable differentiation in vitro and providing immunoisolation in vivo. While multiple encapsulation strategies have been reported, there is typically a tradeoff between the structural complexity of capsules and throughput of their generation. Our paper describes a novel 3D printed microfluidic encapsulation device for fabricating structurally complex microcapsules with a hydrogel shell and aqueous core at rates of up to 1825 Hz. The use of 3D printing allowed to dramatically decrease device footprint when compared to standard soft lithography‐based microfluidic encapsulation devices. Leveraging decreased footprint and the ability to arrange fluidic networks in a 3D space, we fabricated a 10‐nozzle microencapsulation device that generated microcapsules at a rate 10‐times that of the single‐nozzle device. The novel microfluidic device was used to encapsulate hPSCs, human embryonic stem cells (hESCs), and induced pluripotent stem cells (iPSCs). Hydrogel microcapsules with aqueous core promoted hPSCs aggregation into spheroids or embryoid bodies, which maintained high levels of pluripotency. Our technology enables safe and effective encapsulation of hPSCs on a scale (billions of cells) required to treat patients.
Meta-Analysis of the Diagnostic Accuracy of SVEAT, HEART, and TIMI Scores in Predicting Major Adverse Cardiac Events
Tran, Viet Nghi, Pham, Hoang Nhat, Ibrahim, Ramzi, Truong, Hong Hieu, Abdelnabi, Mahmoud, Nguyen, Chau Doan, Nguyen, Thach, Tran, Phillip , Tariq, Haider, Lee, K L, Tran, Viet Nghi, Pham, Hoang Nhat , Ibrahim, Ramzi , Abdelnabi, Mahmoud , Pathangey, Girish , Singh, Amitoj

Mayo Clinic

Current Cardiology Reviews | March 20, 2026 | Volume: 22 | Issue: No issue available | Pages: No page available

10.2174/011573403x387322251203072735 Get It

aims: We assessed the diagnostic accuracy of the SVEAT score in predicting 30-day major adverse cardiac events (MACE) in comparison with the well-established HEART and TIMI scores. background: Acute chest pain (ACP) is a common symptom in emergency departments. Various risk stratification tools have been developed to assess patients presenting with ACP. The Simple Vascular Event Assessment Tool (SVEAT) is the most recent scoring system introduced, based on five variables: Symptoms of chest pain, history of Vascular disease, ECG, Age, and Troponin-I. objective: We assessed the diagnostic accuracy of the SVEAT score in predicting 30-day major adverse cardiac events (MACE) in comparison with the well-established HEART and TIMI scores. method: Following PRISMA guidelines, a systematic literature search was conducted across five databases until June 22, 2024. Four studies comprising 1,520 patients were included in this meta-analysis. The predictive accuracy of the SVEAT, HEART, and TIMI scores for 30-day MACE was assessed by the area under the receiver operating characteristic curve (AUC). Heterogeneity was evaluated using the I² statistic, with values over 75% indicating significant heterogeneity. Indirect comparisons among the scores were performed using the Z-test. result: Pooled AUC for the SVEAT score was 0.92 (95% CI: 0.86-0.98), indicating superior predictive accuracy compared to the HEART (AUC: 0.86, 95% CI: 0.81-0.92) and TIMI (AUC: 0.82, 95% CI: 0.69-0.96) scores. However, significant heterogeneity (I² = 90.6%) was observed across studies, potentially due to variations in patient demographics, clinical settings, and outcome definitions. Despite the higher AUC, indirect Z-test comparisons revealed no statistically significant differences between the scoring systems. conclusion: SVEAT score demonstrates potential as an accurate tool for predicting 30-day MACE in patients with ACP. other: N/A
Vertebral metastatic disease: A paradigm shift
Nguyen, Annee , Trivedi, Trupti, O’Callaghan, Ellen, Yoo, Seeley , Ahmed, Ramzy , Ramos, Rafael De La Garza, Charest-Morin, Raphaële , Sciubba, Daniel, Shin, John H, Laufer, I., Barzilai, Ori, Gokaslan, Z., Sahgal, Arjun, Weber, Michael, Sullivan, Patricia L. Zadnik, Dea, Nicolas, Mullikin, Trey C. , Goodwin, C Rory, Goodwin, C. Rory , Clarke, Michelle, Dea, Nicolas , Goodwin, C Rory , Trivedi, Trupti , O’Callaghan, Ellen , Zachem, Tanner J. , Ramos, Rafael De la Garza , Bilsky, Mark H. , Sciubba, Daniel M. , Clarke, Michelle J. , Tatsui, Claudio Esteves , Laufer, Ilya , Barzilai, Ori , Gokaslan, Ziya L., Sahgal, Arjun , Dea, Nicolas , Lazáry, Áron

Mayo Clinic

Neuro-Oncology Advances | March 20, 2026 | Volume: 8 | Issue: Supplement_3 | Pages: iii21-iii36

10.1093/noajnl/vdag011 | PMID 42221982 Get It

Abstract Vertebral metastatic disease results from many types of cancer and can have a devastating impact on patient mobility, psychological health, quality of life, and ultimately overall patient survival. However, the development of radiotherapy and surgical techniques has rapidly surged in conjunction with ongoing advances in basic science and translational studies. In this review, we discuss the paradigm shift in our understanding of the epidemiology and treatment algorithms for spinal oncology, ranging from preoperative optimization strategies, radiation and surgical techniques, the utilization of molecular markers and targeted therapeutics in medical oncology, and prognostication tools that underscore a new multidisciplinary approach to spinal oncology care.